Historical Background
High mobility group (HMG) chromosomal protein family was first discovered in 1973 (Goodwin and Johns 1973; Goodwin et al. 1973). At that time, the name HMG was defined according to their high electrophoretic mobility in polyacrylamide gels. Then in 1976, α-helix structures of HMGs were identified (Baker et al. 1976; Cary et al. 1976). In 2001, the domains of HMG1 were characterized (Thomas 2001), and at the same year, the HMG Chromosomal Protein Nomenclature Committee recategorized the proteins into three superfamilies: HMGB (formerly known as HMG-1/2), HMGA (formerly known as HMG-14/17), and HMGN (formerly known as HMG-1/Y) (Bustin 2001). Up to date, the functions of HMGB family members have...
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baker C, Isenberg I, Goodwin GH, Johns EW. Physical studies of the nonhistone chromosomal proteins HMG-U and HMG-2. Biochemistry. 1976;15:1645–9.
Bianchi ME, Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genes Dev. 2005;15:496–506. https://doi.org/10.1016/j.gde.2005.08.007.
Bianchi ME, Falciola L, Ferrari S, Lilley DM. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 1992;11:1055–63.
Bonne-Andrea C, Harper F, Sobczak J, De Recondo AM. Rat liver HMG1: a physiological nucleosome assembly factor. EMBO J. 1984;3:1193–9.
Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410:1103–7. https://doi.org/10.1038/35074114.
Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci. 2001;26:152–3.
Cary PD, Crane-Robinson C, Bradbury EM, Javaherian K, Goodwin GH, Johns EW. Conformational studies of two non-histone chromosomal proteins and their interactions with DNA. Eur J Biochem/FEBS. 1976;62:583–90.
Chen GY, Tang J, Zheng P, Liu Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science. 2009;323:1722–5.
Chen R, Hou W, Zhang Q, Kang R, Fan XG, Tang D. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med. 2013;19:357–66. https://doi.org/10.2119/molmed.2013.00099.
Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol. 2012;13:832–42.
Enokido Y, Yoshitake A, Ito H, Okazawa H. Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain. Biochem Biophys Res Commun. 2008;376:128–33. https://doi.org/10.1016/j.bbrc.2008.08.108.
Fages C, Nolo R, Huttunen HJ, Eskelinen E, Rauvala H. Regulation of cell migration by amphoterin. J Cell Sci. 2000;113(Pt 4):611–20.
Gao HM, Zhou H, Zhang F, Wilson BC, Kam W, Hong JS. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J Neurosci. 2011;31:1081–92. https://doi.org/10.1523/JNEUROSCI.3732-10.2011.
Goodwin GH, Johns EW. Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids. Eur J Biochem/FEBS. 1973;40:215–9.
Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem/FEBS. 1973;38:14–9.
Grosschedl R, Giese K, Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 1994;10:94–100.
Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Uchida T, Noguchi T. Dendritic cell activation in response to ischemia-reperfusion injury of the small intestine. Surg Today. 2010;40:137–45. https://doi.org/10.1007/s00595-009-4033-6.
Hayakawa K, Mishima K, Irie K, Hazekawa M, Mishima S, Fujioka M, et al. Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism. Neuropharmacology. 2008;55:1280–6. https://doi.org/10.1016/j.neuropharm.2008.06.040.
Huang H, Nace GW, McDonald KA, Tai S, Klune JR, Rosborough BR, et al. Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection. Hepatology. 2014;59:1984–97.
Huang Y, Yin H, Han J, Huang B, Xu J, Zheng F, et al. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant. 2007;7:799–808. https://doi.org/10.1111/j.1600-6143.2007.01734.x.
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, et al. HMGB1 in health and disease. Mol Asp Med. 2014a;40:1–116. https://doi.org/10.1016/j.mam.2014.05.001.
Kang R, Zhang Q, Hou W, Yan Z, Chen R, Bonaroti J, et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology. 2014b;146:1097–107.
Kao YH, Jawan B, Goto S, Hung CT, Lin YC, Nakano T, et al. High-mobility group box 1 protein activates hepatic stellate cells in vitro. Transplant Proc. 2008;40:2704–5. https://doi.org/10.1016/j.transproceed.2008.07.055.
Kleen JK, Holmes GL. Taming TLR4 may ease seizures. Nat Med. 2010;16:369–70. https://doi.org/10.1038/nm0410-369.
Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 2002;46:2598–603. https://doi.org/10.1002/art.10540.
Lange SS, Mitchell DL, Vasquez KM. High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage. Proc Natl Acad Sci U S A. 2008;105:10320–5. https://doi.org/10.1073/pnas.0803181105.
Lindersson EK, Hojrup P, Gai WP, Locker D, Martin D, Jensen PH. alpha-Synuclein filaments bind the transcriptional regulator HMGB-1. Neuroreport. 2004;15:2735–9.
Mazarati A, Maroso M, Iori V, Vezzani A, Carli M. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products. Exp Neurol. 2011;232:143–8. https://doi.org/10.1016/j.expneurol.2011.08.012.
Nadatani Y, Watanabe T, Tanigawa T, Ohkawa F, Takeda S, Higashimori A, et al. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products. PLoS One. 2013;8:e80130. https://doi.org/10.1371/journal.pone.0080130.
Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 2007;26:1129–39. https://doi.org/10.1038/sj.emboj.7601552.
Pedrazzi M, Averna M, Sparatore B, Patrone M, Salamino F, Marcoli M, et al. Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein. PLoS ONE. 2012;7:31.
Penzo M, Molteni R, Suda T, Samaniego S, Raucci A, Habiel DM, et al. Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]. J Immunol. 2010;184:4497–509.
Qi ML, Tagawa K, Enokido Y, Yoshimura N, Wada Y, Watase K, et al. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat Cell Biol. 2007;9:402–14. https://doi.org/10.1038/ncb1553.
Radin JN, Gonzalez-Rivera C, Ivie SE, McClain MS, Cover TL. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect Immun. 2011;79:2535–43. https://doi.org/10.1128/IAI.01370-10.
Rojas A, Perez-Castro R, Gonzalez I, Delgado F, Romero J, Rojas I. The emerging role of the receptor for advanced glycation end products on innate immunity. Int Rev Immunol. 2014;33:67–80. https://doi.org/10.3109/08830185.2013.849702.
Sato F, Maruyama S, Hayashi H, Sakamoto I, Yamada S, Uchimura T, et al. High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin Pract. 2008;108:c194–201. https://doi.org/10.1159/000118942.
Song JX, Lu JH, Liu LF, Chen LL, Durairajan SS, Yue Z, et al. HMGB1 is involved in autophagy inhibition caused by SNCA/alpha-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B. Autophagy. 2014;10:144–54. https://doi.org/10.4161/auto.26751.
Steer SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med. 2006;3:e17. https://doi.org/10.1371/journal.pmed.0030017.
Takata K, Kitamura Y, Kakimura J, Shibagaki K, Tsuchiya D, Taniguchi T, et al. Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem Biophys Res Commun. 2003;301:699–703.
Thomas JO. HMG1 and 2: architectural DNA-binding proteins. Biochem Soc Trans. 2001;29:395–401.
Topalova D, Ugrinova I, Pashev IG, Pasheva EA. HMGB1 protein inhibits DNA replication in vitro: a role of the acetylation and the acidic tail. Int J Biochem Cell Biol. 2008;40:1536–42. https://doi.org/10.1016/j.biocel.2007.11.014.
Volz HC, Kaya Z, Katus HA, Andrassy M. The role of HMGB1/RAGE in inflammatory cardiomyopathy. Semin Thromb Hemost. 2010;36:185–94. https://doi.org/10.1055/s-0030-1251503.
Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248–51.
Wang X, Xiang L, Li H, Chen P, Feng Y, Zhang J, et al. The role of HMGB1 signaling pathway in the development and progression of hepatocellular carcinoma: a review. Int J Mol Sci. 2015;16:22527–40. https://doi.org/10.3390/ijms160922527.
Watanabe T, Kubota S, Nagaya M, Ozaki S, Nagafuchi H, Akashi K, et al. The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res. 2005;124:59–66. https://doi.org/10.1016/j.jss.2004.10.019.
Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007;117:2847–59. https://doi.org/10.1172/JCI31008.
Xu D, Young J, Song D, Esko JD. Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). J Biol Chem. 2011;286:41736–44. https://doi.org/10.1074/jbc.M111.299685.
Yanai H, Matsuda A, An J, Koshiba R, Nishio J, Negishi H, et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc Natl Acad Sci U S A. 2013;110:20699–704.
Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, et al. A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A. 2010;107:11942–7. https://doi.org/10.1073/pnas.1003893107.
Yang H, Lundback P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, et al. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med. 2012;18:250–9. https://doi.org/10.2119/molmed.2011.00389.
Zlatanova J, Leuba SH, van Holde K. Chromatin structure revisited. Crit Rev Eukaryot Gene Expr. 1999;9:245–55.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Wang, X. (2018). High Mobility Group Box B1. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101643
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_101643
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences